Evaluating the Success of Decentralised Clinical Trials
Senior industry leaders shared their insights
The Financial Times, in partnership with Medidata, was honoured to host this exclusive virtual webinar. Watch this interactive panel discussion to explore what traditional and DCT sponsor representatives and clinical trial participants really think about DCTs. What should stay and what should go? How can sponsors, CROs, and service providers do a better job in optimising experiences for these two essential stakeholder groups? How can innovations be better executed to yield better results?
Rethinking the Role of the Patient
How can sponsors, CROs and service providers do a better job of optimising the trial experience for patients?
Enhancing the Investigator-Patient Relationship
How will DCTs impact site economics, and how will the investigator-patient relationship evolve as DCTs are increasingly mainstreamed?
Expanding the DCT Toolkit
What’s on the horizon in terms of emerging technologies, plug-and-play platforms and new patient-centered services?
World-class business leaders and speakers
The big picture, not just the individual strands of the business you work in
And build relationships with some of the biggest names in your industry
New approaches and strategies to help win market share
Register for free to watch the video on-demand
FT Live Digital Dialogues - fully digital one hour event experiences delivering maximum engagement. Live webinars provide unique opportunities to engage global senior audiences. All access, digital passes include access to all the live sessions PLUS all sessions on demand for 30 days. Join the conversation.
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice